The 2013 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease (CKD) provides guidance on lipid management and treatment for all patients with CKD (non-dialysis-dependent, dialysis-dependent, kidney transplant recipients and children).
Is KDIGO supported by sponsors?
Sponsorship Statement: KDIGO is supported by a consortium of sponsors and no funding is accepted for the development of specific guidelines. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease vTables and Figures vii KDIGO Board Members viii Reference Keys x CKD Nomenclature xi Conversion Factors & HbA
Who are the co-chairs of KDIGO?
Garabed Eknoyan, MD Norbert Lameire, MD, PhD Founding KDIGO Co-Chairs Kai-Uwe Eckardt, MD Immediate Past Co-Chair Bertram L Kasiske, MD KDIGO Co-Chair David C Wheeler, MD, FRCP KDIGO Co-Chair Omar I Abboud, MD, FRCP Sharon Adler, MD, FASN Rajiv Agarwal, MD Sharon P Andreoli, MD Gavin J Becker, MD, FRACP Fred Brown]
What are the keykdigo guidelines?
KDIGO guidelines focus on topics related to the prevention or management of individuals with kidney diseases.
The Kidney Disease: Improving Global Outcomes (KDIGO) group classification was proposed on the basis of the Risk, Injury, Failure, Loss of Kidney Function, and End-stage Kidney Disease (RIFLE) 4 and the Acute Kidney Injury Network (AKIN) 5 classifications in 2012.
What is the difference between rifle and KDIGO and akin?
KDIGO was more predictive than RIFLE for in-hospital mortality ( P <0.001), but there was no difference between KDIGO and AKIN ( P = 0.12). A higher incidence of AKI was diagnosed according to KDIGO criteria. Patients diagnosed as AKI had a significantly higher in-hospital mortality than non-AKI patients, no matter which criteria were used.
What is the difference between the Akin and KDIGO diagnostic criteria?
Comparing to the AKIN criteria, KDIGO also classifies patients initiating renal replacement therapy (RRT) into stage 3 AKI, but removes the threshold of a 0.5 mg/dl increment for SCr >4 mg/dl in the criteria of stage 3 AKI.6 The comparison of the definitions in three classifications is shown in Table 1.
What is the KDIGO classification of acute kidney injury (AKI)?
Severity of AKI in AKIN is staged over the course of 7 days by fold-change in creatinine from baseline. The latest classification was proposed by the Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, was based on the previous two classifications, and had the aim of unifying the definition of AKI [ 15 ].
The Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents the first KDIGO guideline on this subject.
